Skip to main content


Page 4 of 68

  1. Large deletions and duplications within the low-density lipoprotein receptor (LDLR) gene make up approximately 10% of LDLR pathogenic variants found in Czech patients with familial hypercholesterolemia. The goal ...

    Authors: Kateřina Konečná, Petra Zapletalová, Tomáš Freiberger and Lukáš Tichý
    Citation: Lipids in Health and Disease 2024 23:36
  2. The aim was to establish a 10-year dyslipidemia incidence model, investigating novel anthropometric indices using exploratory regression and data mining.

    Authors: Alireza Takhttavous, Maryam Saberi-Karimian, Somayeh Ghiasi Hafezi, Habibollah Esmaily, Marzieh Hosseini, Gordon A. Ferns, Elham Amirfakhrian, Mark Ghamsary, Majid Ghayour-Mobarhan and Maryam Alinezhad-Namaghi
    Citation: Lipids in Health and Disease 2024 23:33
  3. Extensive research has explored the link between saturated fatty acids (SFAs) and cardiovascular diseases, alongside other biological dysfunctions. Yet, their association with cancer risk remains a topic of de...

    Authors: Jin Mei, Meiyu Qian, Yanting Hou, Maodi Liang, Yao Chen, Cuizhe Wang and Jun Zhang
    Citation: Lipids in Health and Disease 2024 23:32
  4. Measurement of the plasma lipid profile, mainly low-density lipoprotein cholesterol (LDL-C), is widely used in the management of hospitalized patients as part of their cardiometabolic risk assessment. In commo...

    Authors: Or Porat, Marriele Kaplan, Smadar Atlibenkin, Dalia Hasson-Gilad, Amir Karban and Ronen Zalts
    Citation: Lipids in Health and Disease 2024 23:30
  5. As independent and correctable risk factors, disturbances in lipid metabolism are significantly associated with type 2 diabetes mellitus (T2DM). This research investigated the mechanism underlying the lipid-re...

    Authors: Yanling Dai, Chen Qiu, Diandian Zhang, Mianli Li and Weinan Liu
    Citation: Lipids in Health and Disease 2024 23:28
  6. The association between lipid and bone metabolism, particularly the role of high-density lipoprotein cholesterol (HDL-C) in regulating bone mineral density (BMD), is of significant interest. Despite numerous s...

    Authors: Yongbing Sun, Xin Qi, Xuan Wang, Xinbei Lin, Yang Zhou, Yawei Du, Ao Liu, Xue Lv, Jing Zhou, Zhonglin Li, Xiaoling Wu, Zhi Zou, Michael Zhang, Jiadong Zhu, Feifei Shang, Yongli Li…
    Citation: Lipids in Health and Disease 2024 23:27
  7. Lipid disorders are a potent risk factor for cardiovascular diseases. Moreover, the intake of dietary fatty acids has been closely related to blood lipid levels. Therefore, this cross-sectional study examined ...

    Authors: Hyun Ah Kim, Hye Ran Shin and SuJin Song
    Citation: Lipids in Health and Disease 2024 23:25
  8. The residual risks of atherosclerotic cardiovascular disease in statin-treated patients with diabetes remain unclear. This study was conducted to identify factors associated with these residual risks in patien...

    Authors: Chin-Sung Kuo, Nai-Rong Kuo, Yun-Kai Yeh, Yau-Jiunn Lee, Lee-Ming Chuang, Hua-Fen Chen, Ching-Chu Chen, Chun-Chuan Lee, Chih-Cheng Hsu, Hung-Yuan Li, Horng-Yih Ou and Chii-Min Hwu
    Citation: Lipids in Health and Disease 2024 23:24
  9. Ferroptosis, is characterized by lipid peroxidation of fatty acids in the presence of iron ions, which leads to cell apoptosis. This leads to the disruption of metabolic pathways, ultimately resulting in liver...

    Authors: Longfei Dai, Wenkang Yuan, Renao Jiang, Zhicheng Zhan, Liangliang Zhang, Xinjian Xu, Yuyang Qian, Wenqi Yang and Zhen Zhang
    Citation: Lipids in Health and Disease 2024 23:23
  10. Current guidelines are debated when it comes to starting anticoagulant therapy in patients with non-valvular atrial fibrillation (NVAF) and low CHA2DS2-VASc scores (1–2 in women and 0–1 in men). However, these in...

    Authors: Kamila Kamili, Tingting Zheng, Chaodi Luo, Xuan Wang and Gang Tian
    Citation: Lipids in Health and Disease 2024 23:22
  11. The molecular diversity exhibited by diffuse large B-cell lymphoma (DLBCL) is a significant obstacle facing current precision therapies. However, scoring using the International Prognostic Index (IPI) is inade...

    Authors: Zhaoli Zhang, Chong Zhao, Shaoxin Yang, Wei Lu and Jun Shi
    Citation: Lipids in Health and Disease 2024 23:20
  12. Numerous studies have affirmed a robust correlation between residual cholesterol (RC) and the occurrence of cardiovascular disease (CVD). However, the current body of literature fails to adequately address the...

    Authors: Mengjie Zhao, Mengli Xiao, Qin Tan, Jinjin Ji and Fang Lu
    Citation: Lipids in Health and Disease 2024 23:19
  13. The literature describes an inverse association between the values of triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C). This survey was designed to exhibit the features of people with type 2 ...

    Authors: Fatemeh Mohammadi, Amirhossein Yadegar, Soghra Rabizadeh, Aryan Ayati, Seyed Arsalan Seyedi, Seyed Ali Nabipoorashrafi, Alireza Esteghamati and Manouchehr Nakhjavani
    Citation: Lipids in Health and Disease 2024 23:18
  14. The ratio of non-high-density lipoprotein cholesterol (non-HDL-C) to high-density lipoprotein cholesterol (HDL-C) (NHHR) serves as a reliable lipid indicator associated with atherogenic characteristics. Studie...

    Authors: Guangwei Qing, Wenpeng Deng, Yuxin Zhou, Liyun Zheng, Yanlai Wang and Bo Wei
    Citation: Lipids in Health and Disease 2024 23:17
  15. Studies have shown that integrating anlotinib with programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors enhances survival rates among progressive non–small-cell lung cancer (NSCLC) patients l...

    Authors: Li Liu, Shuo Zhang, Hai-Yan Yang, Chun-Hua Zhou, Yi Xiong, Nong Yang and Ye Tian
    Citation: Lipids in Health and Disease 2024 23:16
  16. Cardiovascular diseases (CVD) is the leading cause of death among maintenance hemodialysis patients, with dyslipidemia being a prevalent complication. The paradoxical relationship between cardiovascular outcom...

    Authors: Lin Lin, Jie Teng, Yiqin Shi, Qiwen Xie, Bo Shen, Fangfang Xiang, Xuesen Cao, Xiaoqiang Ding, Xialian Xu and Zhen Zhang
    Citation: Lipids in Health and Disease 2024 23:15
  17. Reducing circulating lipid levels is the centerpiece of strategies for preventing and treating atherosclerotic cardiovascular disease (ASCVD). Despite many available lipid-lowering medications, a substantial r...

    Authors: Jingfei Chen, Zhenfei Fang, Qin Luo, Xiao Wang, Mohamad Warda, Avash Das, Federico Oldoni and Fei Luo
    Citation: Lipids in Health and Disease 2024 23:14
  18. Subclinical hypothyroidism (SCH) is linked to dyslipidaemia and adverse pregnancy outcomes. However, the impact of dyslipidaemia on the outcome of pregnancy in SCH is unclear.

    Authors: Xueran Wang, Enjie Zhang, Zongyuan Tian, Rong Zhao, Kaikun Huang, Shen Gao, Shaofei Su, Shuanghua Xie, Jianhui Liu, Yingyi Luan, Yue Zhang, Zheng Zhang, Yousheng Yan, Wentao Yue, Chenghong Yin and Ruixia Liu
    Citation: Lipids in Health and Disease 2024 23:13
  19. Increased susceptibility to malnutrition and inadequate glycemic control are frequently observed in diabetic patients with coronary artery disease. The assessment of malnutrition is performed using the prognos...

    Authors: Shuaifeng Sun, Yue Wang, Shuo Pang and Xiaofan Wu
    Citation: Lipids in Health and Disease 2024 23:12
  20. Some studies have assessed the predictive role of the atherogenic index of plasma (AIP) for macrovascular diseases. This prospective investigation aimed to elucidate whether AIP is associated with diabetic kid...

    Authors: Jia Zhang, Cong Liu, Ying Peng, Qianhua Fang, Xing Wei, Cui Zhang, Lin Sun, Zhuomeng Hu, Jie Hong, Weiqiong Gu, Weiqing Wang, Juan Shi and Yifei Zhang
    Citation: Lipids in Health and Disease 2024 23:11
  21. Obesity is increasingly recognized as a grave public health concern globally. It is associated with prevalent diseases including coronary heart disease, fatty liver, type 2 diabetes, and dyslipidemia. Prior re...

    Authors: Zekun Zhao, Haipeng Lu, Rui Meng, Zhikang Si, Hui Wang, Xuelin Wang, Jiaqi Chen, Yizhan Zheng, Huan Wang, Jiaqi Hu, Ziqi Zhao, Hongmin Zhu, Jianhui Wu, Xiaoming Li and Ling Xue
    Citation: Lipids in Health and Disease 2024 23:10
  22. The presence of gallstones in both the gallbladder and bile ducts is referred to as cholelithiasis. The prevalence of cholecystolithiasis and bile duct stones differs. Observational and Mendelian randomization...

    Authors: Xing-Ming Xie, Tao Liu and Guo-Ying Wang
    Citation: Lipids in Health and Disease 2024 23:8
  23. The relation of adipose tissue depletion with prognostic outcome of variceal bleeding among cirrhotic patients is still inconclusive. The present work explored whether adipose tissue, which was measured based ...

    Authors: Yongshuai Liu, Huijun Chang, Yunqing Zeng, Jinhou Li, Yueyue Li, Yong Chen, Tao Zhou and Yanjing Gao
    Citation: Lipids in Health and Disease 2024 23:7
  24. Long-chain fatty acids (LCFAs) are involved in regulating multiple physiological processes as signalling molecules. Gas chromatography–mass spectrometry (GC–MS) is widely used to quantify LCFAs. However, curre...

    Authors: XiaoYu Guo, Jianglu Zhou, Hong Yu, Han Cao, Xia Li, Qing Hu and YunQiu Yu
    Citation: Lipids in Health and Disease 2024 23:6
  25. Lipid management in clinic is critical to the prevention and treatment of Chronic kidney disease (CKD), while the manifestations of lipid indicators vary in types and have flexible association with CKD prognosis.

    Authors: Hui-fen Chen, Bing-jie Xiao, Lin-yi Chen, Wen-wei OuYang, Xian-long Zhang, Zhi-ren He, Li-zhe Fu, Fang Tang, Xiao-na Tang, Xu-sheng Liu and Yi-fan Wu
    Citation: Lipids in Health and Disease 2024 23:5
  26. Obstructive sleep apnea (OSA) has a bidirectional association with metabolic syndrome, and insulin resistance (IR). The triglyceride-glucose (TyG) index could be a simply calculated marker of IR in OSA. Howeve...

    Authors: Amir Hossein Behnoush, Amirmohammad Khalaji, Elina Ghondaghsaz, Mahdi Masrour, Zahra Shokri Varniab, Soheil Khalaji and Alessandro Cannavo
    Citation: Lipids in Health and Disease 2024 23:4
  27. In Sub-Saharan Africa, the prevalence of dyslipidemia is on the rise, with studies showing dyslipidemia as a contributing factor to the progression of premalignant lesions to cervical cancer. In Uganda, cervic...

    Authors: Gakii Fridah Mwangi, Nixon Niyonzima, Raymond Atwine, Deusdedit Tusubira, Godfrey R Mugyenyi and Frank Ssedyabane
    Citation: Lipids in Health and Disease 2024 23:3
  28. Dyslipidemia is frequently exhibited in individuals with chronic kidney disease (CKD). Remnant cholesterol (RC), an emerging novel lipid marker, plays an elusive role in CKD progression. This study sought to i...

    Authors: Xuan He, Renfang Zou, Xiaoqiong Du, Kuo Li and Dujuan Sha
    Citation: Lipids in Health and Disease 2024 23:2
  29. Acute pancreatitis (AP) is an unpredictable and potentially fatal disorder. A derailed or unbalanced immune response may be the root of the disease’s severe course. Disorders of lipid metabolism are highly cor...

    Authors: Jifeng Liu, Lei Zhong, Yunshu Zhang, Jingyuan Ma, Tong Xie, Xu Chen, Biao Zhang and Dong Shang
    Citation: Lipids in Health and Disease 2024 23:1
  30. Previous studies demonstrated that mast cells with their degranulated component heparin are the major endogenous factors that stimulate preadipocyte differentiation and promote fascial adipogenesis, and this e...

    Authors: Hanxiao Li, Yingyue Dong, Chunmiao Han, Lisha Xia, Yue Zhang, Tongsheng Chen, Huamin Wang and Guoheng Xu
    Citation: Lipids in Health and Disease 2023 22:222
  31. The purpose of this pilot study was to investigate associations between fibrinogen/fibrin degradation products (FDP) to high density lipoprotein-cholesterol (HDL-C) ratio (FHR) of mothers and the risk of deliv...

    Authors: Bin Zhang, Sijie Xi, Renchen Liu, Xiaoya Han, Wei Long, Xiaosong Yuan and Bin Yu
    Citation: Lipids in Health and Disease 2023 22:221
  32. It remains controversial whether the long-term use of statins or newer nonstatin drugs has a positive effect on human longevity. Therefore, this study aimed to investigate the genetic associations between diff...

    Authors: Han Chen, Xiaoying Zhou, Jingwen Hu, Shuo Li, Zi Wang, Tong Zhu, Hong Cheng and Guoxin Zhang
    Citation: Lipids in Health and Disease 2023 22:220
  33. Patients with type 2 diabetes mellitus (T2DM) are commonly at high risk for developing cognitive dysfunction. Antidiabetic agents might be repurposed for targeting cognitive dysfunction in addition to modulati...

    Authors: Jie Meng, Rui Yan, Chen Zhang, Xueyan Bai, Xingsheng Yang, Yu Yang, Tao Feng and Xin Liu
    Citation: Lipids in Health and Disease 2023 22:219
  34. The prevalence of hypertriglyceridaemia-induced acute pancreatitis (HTG-AP) is increasing due to improvements in living standards and dietary changes. However, currently, there is no clinical multifactor scori...

    Authors: Yi Shuanglian, Zeng Huiling, Lin Xunting, Deng Yifang, Lin Yufen, Xie Shanshan, Si Lijuan and Liu Yunpeng
    Citation: Lipids in Health and Disease 2023 22:218
  35. Colorectal cancer (CRC) is a major global health concern, necessitating the identification of biomarkers and molecular subtypes for improved clinical management. This study aims to evaluate the clinical value ...

    Authors: Jing Han, Shangshang Li, Qiong Zhan, Yuchao Hu, Chaoxiang Zhong, Jie Yang and Zhengcai Qiu
    Citation: Lipids in Health and Disease 2023 22:217
  36. A moderate intake of unsaturated fatty acids (UFA) is associated positively with improved insulin resistance. The aim of this study was to investigate the relationship between the dietary intake of unsaturated...

    Authors: Xiaonan Chen, Jie Gu and Yanyan Huang
    Citation: Lipids in Health and Disease 2023 22:216
  37. Chronic interstitial fibrosis is the primary barrier against the long-term survival of transplanted kidneys. Extending the lifespan of allografts is vital for ensuring the long-term health of patients undergoi...

    Authors: Yang-He Zhang, Bin Liu, Qingfei Meng, Dan Zhang, Hongxia Yang, Guangtao Li, Yuxiong Wang, Honglan Zhou, Zhi-Xiang Xu and Yishu Wang
    Citation: Lipids in Health and Disease 2023 22:215
  38. Steatosis and inflammation are the hallmarks of nonalcoholic steatohepatitis (NASH). Rotundic acid (RA) is among the key triterpenes of Ilicis Rotundae Cortex and has exhibited multipronged effects in terms of...

    Authors: Xing-Yang Shi, Xiao-Min Zheng, Hui-Jie Liu, Xue Han, Lei Zhang, Bei Hu and Shan Li
    Citation: Lipids in Health and Disease 2023 22:214
  39. Bilirubin’s ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes...

    Authors: Xin Bai, Jing Qiao and Hong Zhang
    Citation: Lipids in Health and Disease 2023 22:213
  40. Gastric cancer (GC) is a pressing global clinical issue, with few treatment options and a poor prognosis. The onset and spread of stomach cancer are significantly influenced by changes in lipid metabolism-rela...

    Authors: Jinze Zhang, He Wang, Yu Tian, Tianfeng Li, Wei Zhang, Li Ma, Xiangjuan Chen and Yushan Wei
    Citation: Lipids in Health and Disease 2023 22:212
  41. Cardiac cachexia is a deadly consequence of advanced heart failure that is characterised by the dysregulation of adipose tissue homeostasis. Once cachexia occurs with heart failure, it prevents the normal trea...

    Authors: Yiwei Qu, Yong Wang, Tao Wu, Xue Liu, Huaizhe Wang and Dufang Ma
    Citation: Lipids in Health and Disease 2023 22:211
  42. Simple biochemical and anthropometric measurements such as fasting blood glucose (FBG), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), waist circumference (WC), and body mass index (BMI) are...

    Authors: Anthony Kityo and Sang-Ah Lee
    Citation: Lipids in Health and Disease 2023 22:210
  43. Visceral adiposity index (VAI) and lipid accumulation product (LAP) are comprehensive indicators to evaluate visceral fat and determine the metabolic health of individuals. Carotenoids are a group of naturally...

    Authors: Shaohua Yan, Siyu Chen, Yumiao Liu, Hongbin Liang, Xinlu Zhang, Qiuxia Zhang and Jiancheng Xiu
    Citation: Lipids in Health and Disease 2023 22:209

Annual Journal Metrics

  • 2022 Citation Impact
    4.5 - 2-year Impact Factor
    4.9 - 5-year Impact Factor
    1.358 - SNIP (Source Normalized Impact per Paper)
    1.042 - SJR (SCImago Journal Rank)

    2023 Speed
    2 days submission to first editorial decision for all manuscripts (Median)
    68 days submission to accept (Median)

    2023 Usage 
    1,488 Altmetric mentions